Client News
Filter by:
- Aug 30 2023 ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
- Aug 28 2023 Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
- Aug 23 2023 ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
- Aug 14 2023 ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
- Aug 14 2023 ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA
- Aug 14 2023 Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
- Jul 20 2023 CEL-SCI Announces Closing of Public Offering
- Jul 17 2023 CEL-SCI Announces Pricing of Public Offering
- Jul 17 2023 CEL-SCI Announces Proposed Public Offering of Common Stock
- Jul 14 2023 CEL-SCI Concludes Positive Meeting With U.S. FDA Concerning Multikine’s Approval for Head & Neck Cancer